TABLE 1.
Type of lesion and diagnostic test | Sensitivity (%) (no. of positive results/no. of tested specimens)b |
Pc |
||||||
---|---|---|---|---|---|---|---|---|
Swab | FNA | PB | TS | FNA vs swab | FNA vs PB | FNA vs TS | Swab vs PB | |
Nonulcerative (n = 37) | ||||||||
PCR | NA | 88.9 (32/36) | 87.5 (28/32) | NC (3/3) | 0.86 | |||
Microscopic examination | NA | 58.3 (21/36) | 55.6 (15/27) | NC (1/2) | 0.83 | |||
Ulcerative (n = 73) | ||||||||
PCR | 75.0 (51/68) | 55.6 (40/72) | 66.2 (43/65) | 30.0 (3/10) | 0.02* | 0.20 | 0.13 | 0.26 |
Microscopic examination | 46.4 (32/69) | 22.2 (16/72) | 37.5 (18/48) | 20.0 (1/5) | <.01* | 0.07 | 0.91 | 0.34 |
The diagnostic results for swabs, fine-needle aspirates (FNA), punch biopsy specimens (PB), and surgically excised tissue (TS) from 110 laboratory-confirmed BUD cases presenting with nonulcerative (n = 37) and ulcerative (n = 73) lesions from Ghana (Agogo Presbyterian Hospital, Agroyesum Hospital, Apromase Hospital, and Dunkwa Governmental Hospital) and Togo (Tsévié Regional Hospital) were analyzed. For subgroups with sample sizes of <5, the sensitivity was not calculated (NC). NA, not applicable.
The P values comparing the sensitivities of 2 tests for laboratory diagnosis of BUD (PCR and microscopic examination), stratified into 4 techniques of specimen collection (involving swabs, fine-needle aspirates [FNA], punch biopsy specimens [PB], and surgically excised tissue [TS]), were as follows: for swabs, <0.01 for ulcerative lesions; for FNA, <0.01 for nonulcerative and ulcerative lesions; for PB, <0.01 for nonulcerative and ulcerative lesions; and for TS, 0.68 for ulcerative lesions. P values of <0.05 were considered significant.
The P values comparing the sensitivities of 2 out of 4 techniques of specimen collection (involving swabs, fine-needle aspirates [FNA], punch biopsy specimens [PB], and surgically excised tissue [TS]), stratified into 2 tests for laboratory diagnosis of BUD (PCR and microscopic examination), are given. P values of <0.05 were considered significant (*).